BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Naveed M, Kubiliun N. Endoscopic Treatment of Early-Stage Esophageal Cancer. Curr Oncol Rep. 2018;20:71. [PMID: 30058019 DOI: 10.1007/s11912-018-0713-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Xu Z, Wu Z, Zhang J, Zhou R, Wu J, Yu B. Development of Multiscale Transcriptional Regulatory Network in Esophageal Cancer Based on Integrated Analysis. Biomed Res Int 2020;2020:5603958. [PMID: 32851080 DOI: 10.1155/2020/5603958] [Reference Citation Analysis]
2 Liao F, Zhu Z, Lai Y, Pan X, Long S, Zhou X, Li G, Zhu Y, Chen Y, Shu X. Risk Factors for Fever After Esophageal Endoscopic Submucosal Dissection and Its Derived Technique. Front Med (Lausanne) 2022;9:713211. [PMID: 35273969 DOI: 10.3389/fmed.2022.713211] [Reference Citation Analysis]
3 Syed T, Doshi A, Guleria S, Syed S, Shah T. Artificial Intelligence and Its Role in Identifying Esophageal Neoplasia. Dig Dis Sci 2020;65:3448-55. [PMID: 33057945 DOI: 10.1007/s10620-020-06643-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Li N, Jin SZ. Artificial intelligence and early esophageal cancer. Artif Intell Gastrointest Endosc 2021; 2(5): 198-210 [DOI: 10.37126/aige.v2.i5.198] [Reference Citation Analysis]
5 Wei MT, Friedland S. Early Esophageal Cancer: What the Gastroenterologist Needs to Know. Gastroenterol Clin North Am 2021;50:791-808. [PMID: 34717871 DOI: 10.1016/j.gtc.2021.07.004] [Reference Citation Analysis]
6 Iriarte F, Su S, Petrov RV, Bakhos CT, Abbas AE. Surgical Management of Early Esophageal Cancer. Surg Clin North Am 2021;101:427-41. [PMID: 34048763 DOI: 10.1016/j.suc.2021.03.005] [Reference Citation Analysis]
7 Zheng Y, Yang P, Chen J, Yu K, Ye Y, Zhang L, Hou X, Wang D. Endoscopic excision as a viable alternative to major resection for early duodenal cancers: A population-based cohort study. Int J Surg 2022;101:106644. [PMID: 35500880 DOI: 10.1016/j.ijsu.2022.106644] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wang HY, Zeng X, Bai SY, Pu K, Zheng Y, Ji R, Guo QH, Guan QL, Wang YP, Zhou YN. The safety and efficacy of endoscopic submucosal dissection for treating early oesophageal carcinoma: a meta-analysis. Ann R Coll Surg Engl 2020;102:702-11. [PMID: 32820658 DOI: 10.1308/rcsann.2020.0177] [Reference Citation Analysis]
9 Jiang KY, Huang H, Chen WY, Yan HJ, Wei ZT, Wang XW, Li HX, Zheng XY, Tian D. Risk factors for lymph node metastasis in T1 esophageal squamous cell carcinoma: A systematic review and meta-analysis. World J Gastroenterol 2021; 27(8): 737-750 [PMID: 33716451 DOI: 10.3748/wjg.v27.i8.737] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Zhang BZ, Zhang Y, Wang YD, Liao Y, Zhang JJ, Wu YF, Xiao TY, Sun SY, Guo JT. Stent placement to prevent strictures after esophageal endoscopic submucosal dissection: a systematic review and meta-analysis. Dis Esophagus 2021;34:doab015. [PMID: 33786604 DOI: 10.1093/dote/doab015] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Goyal H, Sherazi SAA, Mann R, Gandhi Z, Perisetti A, Aziz M, Chandan S, Kopel J, Tharian B, Sharma N, Thosani N. Scope of Artificial Intelligence in Gastrointestinal Oncology. Cancers (Basel) 2021;13:5494. [PMID: 34771658 DOI: 10.3390/cancers13215494] [Reference Citation Analysis]
12 Yoshida M, Takizawa K, Nonaka S, Shichijo S, Suzuki S, Sato C, Komori H, Minagawa T, Oda I, Uedo N, Hirasawa K, Matsumoto K, Sumiyoshi T, Mori K, Gotoda T, Ono H, Yoshida M, Takizawa K, Ono H, Mori K, Nonaka S, Oda I, Shichijo S, Uedo N, Suzuki S, Kusano C, Gotoda T, Sato C, Hirasawa K, Komori H, Takeda T, Matsumoto K, Minagawa T, Fujii R, Sumiyoshi T, Yamasaki Y, Minashi K, Nakajima T, Kurokawa Y. Conventional versus traction-assisted endoscopic submucosal dissection for large esophageal cancers: a multicenter, randomized controlled trial (with video). Gastrointestinal Endoscopy 2020;91:55-65.e2. [DOI: 10.1016/j.gie.2019.08.014] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
13 Ji Y, Liu Y, Xue N, Du T, Wang L, Huang R, Li L, Yan C, Chen X. Cryptotanshinone inhibits esophageal squamous-cell carcinoma in vitro and in vivo through the suppression of STAT3 activation. Onco Targets Ther 2019;12:883-96. [PMID: 30774375 DOI: 10.2147/OTT.S187777] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
14 Xu QL, Li H, Zhu YJ, Xu G. The treatments and postoperative complications of esophageal cancer: a review. J Cardiothorac Surg. 2020;15:163. [PMID: 32631428 DOI: 10.1186/s13019-020-01202-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 Feng Y, Wei W, Guo S, Li BQ. Associated risk factor analysis and the prognostic impact of positive resection margins after endoscopic resection in early esophageal squamous cell carcinoma. Exp Ther Med 2022;24:457. [PMID: 35747151 DOI: 10.3892/etm.2022.11384] [Reference Citation Analysis]
16 Xian Q, Zhu D, Zheng D. The Involvement of WDHD1 in the Occurrence of Esophageal Cancer as a Downstream Target of PI3K/AKT Pathway. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/5871188] [Reference Citation Analysis]
17 Liu B, Zhao N, Zhou Y, Lu Y, Chen W, Huang Z, Wang D, Xu Y, Wai Ping Yam J, Cui Y. Circular RNA circ_ABCB10 in cancer. Clin Chim Acta 2021;518:93-100. [PMID: 33746018 DOI: 10.1016/j.cca.2021.03.010] [Reference Citation Analysis]
18 Qin J, Zhu Y, Ding Y, Niu T, Zhang Y, Wu H, Zhu L, Yuan B, Qiao Y, Lu J, Liu K, Dong Z, Jin G, Chen X, Zhao J. DNA polymerase β deficiency promotes the occurrence of esophageal precancerous lesions in mice. Neoplasia 2021;23:663-75. [PMID: 34144266 DOI: 10.1016/j.neo.2021.05.001] [Reference Citation Analysis]